Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma von Ricke, Jens, Klümpen, Heinz Josef, Amthauer, Holger, Bargellini, Irene, Bartenstein, Peter, de Toni, Enrico N., Gasbarrini, Antonio, Pech, Maciej, Peck-Radosavljevic, Markus, Popovič, Peter, Rosmorduc, Olivier, Schott, Eckart, Seidensticker, Max, Verslype, Chris, Sangro, Bruno, Malfertheiner, Peter

Volltext

Use of checkpoint inhibitors in liver transplant recipients von Munker, Stefan, De Toni, Enrico N

Volltext

Follistatin‐controlled activin‐HNF4α‐coagulation factor axis in liver progenitor cells determines outcome of acute liver failure von Lin, Tao, Wang, Shanshan, Munker, Stefan, Jung, Kyounghwa, Macías‐Rodríguez, Ricardo U., Ruiz‐Margáin, Astrid, Schierwagen, Robert, Liu, Hui, Shao, Chen, Fan, Chunlei, Feng, Rilu, Yuan, Xiaodong, Wang, Sai, Wandrer, Franziska, Meyer, Christoph, Wimmer, Ralf, Liebe, Roman, Kroll, Jens, Zhang, Long, Schiergens, Tobias, ten Dijke, Peter, Teufel, Andreas, Marx, Alexander, Mertens, Peter R., Wang, Hua, Ebert, Matthias P.A., Bantel, Heike, De Toni, Enrico, Trebicka, Jonel, Dooley, Steven, Shin, Donghun, Ding, Huiguo, Weng, Hong‐Lei

Volltext

Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study von Xia, Bin, Peng, Jianjun, Enrico, De Toni, Lu, Kuiqing, Cheung, Eddie C., Kuo, Zichong, He, Qiangsheng, Tang, Yan, Liu, Anran, Fan, Die, Zhang, Changhua, He, Yulong, Pan, Yihang, Yuan, Jinqiu

Volltext

Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity von Shatila, Malek, Ma, Weijie, Cui, Yantong, Naz, Sidra, S. Thomas, Anusha, N. De Toni, Enrico, Török, Helga-Paula, Khaled, Najib Ben, Altan, Mehmet, Schneider, Bryan, Wang, Yinghong

Volltext

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis... von Öcal, Osman, Schütte, Kerstin, Kupčinskas, Juozas, Morkunas, Egidijus, Jurkeviciute, Gabija, de Toni, Enrico N., Ben Khaled, Najib, Berg, Thomas, Malfertheiner, Peter, Klümpen, Heinz Josef, Sengel, Christian, Basu, Bristi, Valle, Juan W., Benckert, Julia, Gasbarrini, Antonio, Palmer, Daniel, Seidensticker, Ricarda, Wildgruber, Moritz, Sangro, Bruno, Pech, Maciej, Ricke, Jens, Seidensticker, Max

Volltext

Correlation Between Baseline Osteoprotegerin Serum Levels and Prognosis of Advanced-Stage Colorectal Cancer Patients von De Toni, Enrico, Nagel, Dorothea, Philipp, Alexander B., Herbst, Andreas, Thalhammer, Isabel, Mayerle, Julia, Török, Helga-Paula, Brandl, Lydia, Kolligs, Frank T.

Volltext

Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) - a multicenter, randomized, controlled, open-label investigato... von Schmidt, Constantin, Zapf, Antonia, Ozga, Ann-Kathrin, Canbay, Ali, Denzer, Ulrike, De Toni, Enrico N, Lohse, Ansgar W, Schulze, Kornelius, Rösch, Thomas, Stein, Alexander, Wege, Henning, von Felden, Johann

Volltext

Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients von Munker, Dieter, Osterman, Andreas, Stubbe, Hans, Muenchhoff, Maximilian, Veit, Tobias, Weinberger, Tobias, Barnikel, Michaela, Mumm, Jan-Niclas, Milger, Katrin, Khatamzas, Elham, Klauss, Sarah, Scherer, Clemens, Hellmuth, Johannes C., Giessen-Jung, Clemens, Zoller, Michael, Herold, Tobias, Stecher, Stephanie, de Toni, Enrico N., Schulz, Christian, Kneidinger, Nikolaus, Keppler, Oliver T., Behr, Juergen, Mayerle, Julia, Munker, Stefan

Volltext

The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma von Ye, Liangtao, Mayerle, Julia, Ziesch, Andreas, Reiter, Florian P., Gerbes, Alexander L., De Toni, Enrico N.

Volltext

Immune checkpoint inhibitors: use them early, combined and instead of TACE? von De Toni, Enrico N

Volltext

Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management von Ye, Liangtao, Schneider, Julia S., Ben Khaled, Najib, Schirmacher, Peter, Seifert, Carolin, Frey, Lea, He, Yulong, Geier, Andreas, De Toni, Enrico N., Zhang, Changhua, Reiter, Florian P.

Volltext

Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting von Gerum, Sabine, Heinz, Christian, Belka, Claus, Walter, Franziska, Paprottka, Philipp Marius, De Toni, Enrico N, Roeder, Falk

Volltext

Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma von Spahn, Stephan, Roessler, Daniel, Pompilia, Radu, Gabernet, Gisela, Gladstone, Beryl Primrose, Horger, Marius, Biskup, Saskia, Feldhahn, Magdalena, Nahnsen, Sven, Hilke, Franz J., Scheiner, Bernhard, Dufour, Jean-Francois, De Toni, Enrico N., Pinter, Matthias, Malek, Nisar P., Bitzer, Michael

Volltext

Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma von De Toni, Enrico N, Roessler, Daniel

Volltext

Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells von Koch, Dominik T, Yu, Haochen, Beirith, Iris, Schirren, Malte, Drefs, Moritz, Liu, Yunfei, Knoblauch, Mathilda, Koliogiannis, Dionysios, Sheng, Weiwei, De Toni, Enrico N, Bazhin, Alexandr V, Renz, Bernhard W, Guba, Markus O, Werner, Jens, Ilmer, Matthias

Volltext

Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery von Gallmeier, Eike, Bader, Dominik C, Kriegl, Lydia, Berezowska, Sabina, Seeliger, Hendrik, Göke, Burkhard, Kirchner, Thomas, Bruns, Christiane, De Toni, Enrico N

Volltext

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease von Gerum, Sabine, Heinz, Christian, Belka, Claus, Walter, Franziska, Paprottka, Philipp, De Toni, Enrico N, Roeder, Falk

Volltext

Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient von De Toni, Enrico N, Gerbes, Alexander L

Volltext

IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease von Hohenester, Simon, Kanitz, Veronika, Schiergens, Tobias, Einer, Claudia, Nagel, Jutta, Wimmer, Ralf, Reiter, Florian P., Gerbes, Alexander L., De Toni, Enrico N., Bauer, Christian, Holdt, Lesca, Mayr, Doris, Rust, Christian, Schnurr, Max, Zischka, Hans, Geier, Andreas, Denk, Gerald

Volltext